In vitro effects of toxogonin, HI-6 and HLö-7 on the release of [3H]acetylcholine from peripheral cholinergic nerves in rat airway smooth muscle

European Journal of Pharmacology

Volumn 301, Issue 1-3, 1996, Pages 59-66

  Aas, Pål ^a  

^a NORWEGIAN DEFENCE RESEARCH ESTABLISHMENT FFI   (Norway)

Author keywords

Acetylcholine; Ca2+; Channel; HI 6; HL 7; Oxime; Phosphorylation; Protein kinase inhibitor; Soman; Toxogonin

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; 1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 1 [2,4 BIS(HYDROXYIMINOMETHYL)PYRIDINIO] 1' (4 CARBAMOYLPYRIDINIO)DIMETHYL ETHER DIIODIDE; 1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; ACETYLCHOLINE; ACETYLCHOLINESTERASE; ATROPINE; CALCIUM ANTAGONIST; CALCIUM CHANNEL; CALPHOSTIN C; CHOLINE; CHOLINESTERASE; METHOCTRAMINE; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR BLOCKING AGENT; N (2 GUANIDINOETHYL) 5 ISOQUINOLINESULFONAMIDE; OBIDOXIME; OMEGA AGATOXIN IVA; OMEGA CONOTOXIN GVIA; OXIME DERIVATIVE; OXOTREMORINE; PHORBOL DIBUTYRATE; PIRENZEPINE; POTASSIUM ION; PROFENAMINE; PROTEIN KINASE INHIBITOR; RADIOISOTOPE; SOMAN; VERAPAMIL;

ACETYLCHOLINE RELEASE; AIRWAY; ANIMAL TISSUE; ARTICLE; BRONCHUS MUSCLE; CHOLINERGIC NERVE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; MALE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; BRONCHI; CALCIUM CHANNEL BLOCKERS; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; ENZYME ACTIVATION; MALE; MUSCLE, SMOOTH; OBIDOXIME CHLORIDE; PARASYMPATHETIC NERVOUS SYSTEM; PERIPHERAL NERVES; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; PSEUDOCHOLINESTERASE; PYRIDINES; PYRIDINIUM COMPOUNDS; RATS; RATS, WISTAR; SOMAN;

EID: 0029950654     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00027-1     Document Type: Article

References (43)

1. Aas, P. and F. Fonnum, 1986. Presynaptic inhibition of acetylcholine release. Acta Physiol. Scand. 127, 335.
2. 2 muscarinic receptors in pulmonary cholinergic nerves in the rat, Br. J. Pharmacol. 101, 73.
3. 3H-acetylcholine release in the isolated rat bronchi, Pharmacol. Toxicol. 60, 206.
4. Alkondon, M., K.S. Rao and E.X. Albuquerque, 1988, Acetylcholinesterase reactivators modify the functional properties of the nicotinic acetylcholine receptor ion-channel, J. Pharmacol. Exp. Ther. 245, 534.
5. Barrie, A.P., D.G. Nicholls, J. Sanchez-Prieto and T.S. Sihra, 1991, An ion channel locus for the protein kinase C potentiation of transmitter glutamate release from guinea-pig cerebrocortical synaptosomes, J. Neurochem. 57, 4, 1398.
6. Berends, F., 1987. Mechanisms of ageing of organophosphate-inhibited esterases, in: Structure of Molecular Mechanisms in Toxicity, eds. F. De Matteis and E.A. Lock (McMillan Press, UK) p. 125.
7. Boskovic, B., V. Kovacevic and D. Jovanovic, 1984, PAM-2 Cl, HI-6 and HGG 12 in soman and tabun poisoning. Fund. Appl. Toxicol. 4, 106.
8. Bowman, W.C., C. Prior and I.G. Marshall, 1990, Presynaptic receptors in the neuromuscular junction, Ann. NY. Acad. Sci. 604, 69.
9. Bromfield, C., I.J. Dembure and J. Cuculis, 1987, Binding of soman antidotes to acetylcholine receptors, Biochem. Pharmacol. 30, 1017.
10. Clement, J.G., 1981, Toxicology and pharmacology of bispyridinium oximes-insight into the mechanism of action versus soman poisoning in vivo, Fundam. Appl. Toxicol. 1, 193.
11. Clement, J.G., 1982, Reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat, Biochem. Pharmacol. 31, 1283.
12. Clement, J.G., 1983, Efficacy of mono- and bis-pyridinium oximes versus soman, sarin and tabun poisoning in mice, Fundam. Appl. Toxicol. 3, 533.
13. Clement, J.G., J.D. Shiloff and C. Gennings, 1987, Efficacy of combination of acetylcholinesterase reactivators. HI-6 and obidoxime against tabun and soman poisoning of mice, Arch. Toxicol. 61, 70.
14. DeJong, L.P.A. and G. Wolring, 1980, Reactivation of acetylcholinesterase inhibited by 1,2,2′-trimethylpropyl methylphosphonofluoridate (soman) with HI-6 and related oximes, Biochem. Pharmacol. 29, 2379.
15. DeJong, L.P.A. and G. Wolring, 1984, Stereospecific reactivation by some Hagedorn-oximes of acetylcholinesterases from various species including man, inhibited by soman, Biochem. Pharmacol. 33, 1119.
16. DeJong, L.P.A., M. Verhagen, J. Langenberg, I. Hagedorn and M. Löffler, 1989, The bispyridinium dioxime HLö-7, a potent reactivator for acetylcholinesterase inhibited by stereoisomers of tabun and soman, Biochem. Pharmacol. 38, 633.
17. 2+-channels in mammalian central neurons, Trends Neurosci. 18, 2, 89.
18. Eyer, P., I. Hagedorn, R. Klimmek, P. Lippstreu, H. Oldiges, U. Spöhrer, I. Steidl, L. Szinicz and F. Worek, 1992, HLö-7 dimethanesulfonate, a potent bispyridinium-dioxime against anticholinesterases, Arch. Toxicol. 66, 603.
19. Greengard, P., M.D. Browning, T.L. McGuinness and R. Llinás, 1987, Synapsin I, a phosphoprotein associated with synaptic vesicles: possible role in the regulation of neurotransmitter release, Adv. Exp. Med. Biol. 221, 135.
20. Hamilton, M.G. and P.M. Lundy, 1989, HI-6 therapy of soman and tabun poisoning in primates and rodents, Arch. Toxicol. 63, 144.
21. Heilbronn, E. and B. Tolagen, 1965, Toxogonin in sarin, soman and tabun poisoning, Biochem. Pharmacol. 14, 73.
22. Inns, R.H. and L. Leadbeater, 1983, The efficacy of bispyridinium derivatives in the treatment of organophosphosphonate poisoning in the guinea-pig, J. Pharm. Pharmacol. 35, 427.
23. Loomis, T.A. and B. Salafsky, 1963, Antidotal action of pyridinium oximes in anticholineaterase poisoning, comparative effects of soman, sarin and neostigmine on neuromuscular function, Toxicol. Appl. Pharmacol. 5, 685.
24. Lundy, P.M., A.S. Hansen, B.T. Hand and C.A. Boulet, 1992, Comparison of several oximes against poisoning by soman, tabun and GF, Toxicology 72, 99.
25. Melchers, B.P.C., A.L. Van der Laaken and H.P.M. Van Helden, 1991, On the mechanism whereby HI-6 improves neuromuscular function after oxime-resistant acetylcholinesterase inhibition and subsequent impairment of neuromuscular transmission, Eur. J. Pharmacol. 200, 331.
26. Oldiges, H. and K. Schoene, 1970, Pyridinium and Imidazolinium Salze als Antidote gegen Soman und Paraoxon vergiftungen bei Mause, Arch. Toxicol. 26, 293.
27. Richardson, I.W. and J.C. Szerb, 1974, The release of labelled acetylcholine and choline from cortical slices stimulated electrically, Br. J. Pharmacol. 52, 499.
28. Schoene, K., J. Steinhanses and H. Oldiges, 1976, Protective activity of pyridinium salts against soman poisoning in vivo and in vitro, Biochem. Pharmacol. 25, 1955.
29. Smith, A.P. and A.W. Muir, 1977, Antidotal action of the oxim HS-6 at the soman poisoned neuromuscular junction of the rat and the guinea-pig, J. Pharm. Pharmacol. 29, 762.
30. Sterri, S.H. and F. Fonnum, 1978, Isolation of organic anions by extraction with liquid anion exchangers and its application to micromethods for acetylcholinesterase and 4-aminobutyrate aminotransferase, Eur. J. Biochem. 91, 215.
31. Su, C., C. Tang, C. Ma, Y. Shih, C. Liu and M. Wu, 1983, Quantitative structure-activity relationships and possible mechanisms of action of bispyridinium oximes as antidotes against pinacolyl methylphosphonofluoridate, Fund. Appl. Toxicol. 3, 271.
32. Tattersall, J.E., 1993, Ion channel blockade by oximes and recoveray of diaphragm muscle from soman poisoning in vitro, Br. J. Pharmacol. 108, 1006.
33. Taylor, P., 1990, Anticholinesterase agents, in: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th edn., eds. A.G. Gilman, T.W. Rail, A.S. Nies and P. Taylor (Pergamon Press, New York, USA) p. 131.
34. Todrik, A., 1954, The inhibition of cholinesterases by antagonists of acetylcholine and histamine, Br. J. Pharmacol. 9, 76.
35. 2+ / calmodulin-dependent protein kinase II, J. Biol. Chem. 265, 8, 4315.
36. Van Helden, H.P.M., J. De Lange, R.W. Busker and B.PC. Melchers, 1991, Therapy of organophosphate poisoning in the rat by direct effects of oximes unrelated to ChE reactivation, Arch. Toxicol. 65, 586.
37. Van Helden, H.P.M., H.J. Van der Wiel, J. De Lange, R.W. Busker, B.P.C. Melchers and O.L. Wolthuis, 1992, Therapeutic efficacy of HI-6 in soman poisoned marmoset monkeys, Toxicol. Appl. Pharmacol. 115, 50.
38. Van Helden, H.P.M., H. Van der Wiel, J.J. Zijlstra, B.P. Melchers and R. Busker, 1994, Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholineaterase inhibition in rats, Arch. Toxicol. 68, 224.
39. Walday, P., P. Aas, T. Haider and F. Fonnum, 1993, Effect of pyridostigmine pretreatment, HI-6 and toxogonin treatment on rat tracheal smooth muscle response to cholinergic stimulation after organophosphorus inhalation exposure, Arch. Toxicol. 67, 212.
40. Wessler, I., 1989, Control of transmitter release from the motor nerve by presynaptic nicotinic and muscarinic autoreceptors, Trends Pharmacol. Sci. 10, 110.
41. Wolthuis, O.L., R.A.P. Vanwersch and H.J. Van der Wiel, 1981, The efficacy of some bispyridinium oximes as antidotes to soman in isolated muscles of several species including man, Eur. J. Pharmacol. 70, 355.
42. Worek, F., T. Kirchner and L. Szinicz, 1994, Treatment of tabun poisoned guinea-pig with atropine, HLö-7 or HI-6: effect on respiratory and circulatory function, Arch. Toxicol. 68, 231.
43. Yamamura, H.I. and S.H. Snyder, 1973, High affinity transport of choline into synaptosomes of rat brain, J. Neurochem. 21, 1355.